0001209191-18-034891.txt : 20180601
0001209191-18-034891.hdr.sgml : 20180601
20180601212629
ACCESSION NUMBER: 0001209191-18-034891
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180523
FILED AS OF DATE: 20180601
DATE AS OF CHANGE: 20180601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levine Mitchell S
CENTRAL INDEX KEY: 0001383492
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 18876728
MAIL ADDRESS:
STREET 1: ONE FERRY BUILDING, SUITE 255
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoCyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 510-775-0515
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-23
0
0001642380
OncoCyte Corp
OCX
0001383492
Levine Mitchell S
1010 ATLANTIC AVE, SUITE 102
ALAMEDA
CA
94501
0
1
0
0
Chief Financial Officer
Option to Purchase Common Stock
2.35
2018-05-23
4
A
0
50000
0.00
A
2028-05-22
Common Stock
50000
50000
D
Option to Purchase Common Stock
2.35
2018-05-23
4
A
0
125000
0.00
A
2028-05-22
Common Stock
125000
125000
D
Option to Purchase Common Stock
5.90
2027-11-14
Common Stock
200000
200000
D
One quarter of the options shall vest on the one-year anniversary of the grant date and the balance shall vest thereafter in 36 equal monthly installments.
These options vest as to one-third of the shares on each of the completion of the clinical utility study for OncoCyte's DetermaVu product candidate, the filing of the Medicare dossier for the Medicare local coverage determination, and obtaining a Medicare local coverage determination for OncoCyte's DetermaVu product candidate.
One quarter of the options shall vest on November 14, 2018, subject to the completion of 12 months of continuous employment from the date of grant, and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant.
/s/Mitchell S. Levine
2018-06-01